Tagraxofusp: Phase 1 Study (+/- chemotherapy) in Pediatric Patients with R/R CD123 expressing Heme Malignancies

Phase I Study of Tagraxofusp +/- Chemotherapy in Pediatric Patients with R/R CD123-Expressing Hematologic Malignancies: A TACL Consortium Trial. ASH 2022.

Poster